Skip to content

PEPFAR and Global Fund both highly effective, but is the funding sustainable?

Is PEPFAR competing or cooperating in treatment scale-up?

Better than expected 'real world' benefits seen in highly treatment-experienced patients on atazanavir

Condoms reduce women's risk of contracting genital HPV, proves US study

'Opt out' HIV testing for all at UK sexual health clinics

Fat loss beginning to trigger treatment changes in South African patients

Tipranavir study halted in treatment-naive

Monitoring antiretroviral treatment with limited laboratory services

BHIVA issues draft briefing paper on UK law and HIV transmission